US Subsidiary, LED Dental Ltd., Appoints Michael Dunn as Director of Marketing

BURNABY, British Columbia – December 20, 2013 - LED Medical Diagnostics Inc. ("LED Medical, the Company") announced today that its wholly-owned subsidiary, LED Dental Ltd. (“LED Dental”) has appointed Mr. Michael Dunn to the role of Director of Marketing.

Immediately prior to joining LED Dental, Mr. Dunn was the VP of Distance Education & Marketing at Spear Education, where his responsibilities included directing sales and marketing activities to drive revenue for a new online Dental Continuing Education platform as well as managing marketing, communications, video production, and inside sales teams. "Michael has a deep marketing background in dental technology with a particular emphasis in digital dentistry technologies and services," states Dr. David Gane, CEO of LED Medical. "He is well respected for his marketing successes within the industry and I'm sincerely pleased that he's joined our team."

Previously, Mr. Dunn was the VP Marketing for OralDNA Labs where, among his responsibilities, he managed US marketing initiatives, professional relations and served as a company liaison to various industry associations and KOLs. Mr. Dunn also served in several marketing leadership roles in both the US and Germany within Sirona Dental Systems' CAD/CAM division. His breadth of experience with marketing, new client acquisition and relationship management within the dental market will add significant strength to the sales and marketing team for LED Dental - as the company focuses on growth and market penetration for its VELscope® VX technology.

About the VELscope® Vx

The distinctive blue-spectrum light of the VELscope® Vx hand-held device causes the soft tissues of the mouth to naturally fluoresce. Healthy tissues fluoresce in distinct patterns that are visibly disrupted by trauma or disease, such as neoplastic lesions, chemical irritation, side-effects from medication, thermal damage, fungal, viral or bacterial infections. Use of the VELscope® Vx allows a wide variety of oral abnormalities to be discovered, often before they're visible to the unassisted eye. The VELscope® Vx is further intended to be used by oral surgeons as a tool to assist in identifying diseased tissue around a clinically apparent lesion and thus aid in determining the appropriate margin for surgical excision. It is also the only tissue fluorescence device with photo/video documentation capabilities through the viewing mechanism, a key function for referrals and patient records.

About LED Medical Diagnostics Inc.

Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc. is a leading developer of LED-based visualization technologies for the medical industry. The Company is currently listed on the Toronto Stock Exchange (TSX-V) under the symbol "LMD", the OTCQX under the symbol "LEDIF", as well as the Frankfurt Stock Exchange under the symbol "LME". For more information, visit www.ledmd.com.

Through its wholly-owned subsidiary, LED Dental Inc., the company manufactures the VELscope® Vx Enhanced Oral Assessment System, the first system in the world to apply tissue fluorescence visualization technology to the oral cavity. VELscope® Vx devices are now used to conduct more screenings for oral cancer and other oral diseases than any other adjunctive device. To date, there have been more than 12,000 VELscope® Vx systems sold globally and they have been used to perform more than 25 million exams. For more information, call 604.434.4614 or visit www.leddental.com.

For media or investor relations inquiries, please contact:

Mark Komonoski
Investor Relations
LED Medical Diagnostics Inc.
TSX.V: LMD | OTCQX: LEDIF | FSE: LME

Toll-Free: 877.255.8483
Office: 403.255.8483
Mobile: 403.470.8384
E-Mail:
Skype: mkomonoski